Corcept Therapeutics (CORT) Work In Process (2012 - 2026)

Corcept Therapeutics (CORT) has 15 years of Work In Process data on file, last reported at $11.8 million in Q1 2026.

• For the quarter ending Q1 2026, Work In Process rose 67.86% year-over-year to $11.8 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (up 67.86% YoY), and the FY2025 full-year result was $13.7 million, up 75.93% from the prior year.
• Work In Process eased to $11.8 million in Q1 2026, from $13.7 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $14.2 million in Q3 2025 to a low of $6.7 million in Q2 2023.
• A 5-year average of $9.7 million and a median of $8.5 million in 2023 frame the typical range for Work In Process.
• Across the five-year window, Work In Process sank 41.28% in 2023 and jumped 82.86% in 2025, its largest moves.
• Tracing CORT's Work In Process over 5 years: stood at $7.8 million in 2022, then climbed by 5.19% to $8.2 million in 2023, then dropped by 5.39% to $7.8 million in 2024, then surged by 75.93% to $13.7 million in 2025, then decreased by 13.82% to $11.8 million in 2026.
• Business Quant data shows CORT's Work In Process at $11.8 million in Q1 2026, $13.7 million in Q4 2025, and $14.2 million in Q3 2025.